Pages that link to "Q38131751"

The following pages link to SUMO and Parkinson's disease (Q38131751):

Displaying 23 items.

• Sumoylation in Synaptic Function and Dysfunction (Q26747536) (← links)
• Direct and/or Indirect Roles for SUMO in Modulating Alpha-Synuclein Toxicity (Q26799306) (← links)
• Predicting sumoylation sites using support vector machines based on various sequence features, conformational flexibility and disorder (Q30614500) (← links)
• GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs. (Q33860670) (← links)
• Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction (Q34295237) (← links)
• Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development (Q35832364) (← links)
• Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast (Q38444052) (← links)
• Battling Alzheimer's Disease: Targeting SUMOylation-Mediated Pathways (Q38557970) (← links)
• A high-yield double-purification proteomics strategy for the identification of SUMO sites. (Q38750217) (← links)
• SUMO-regulated mitochondrial function in Parkinson's disease (Q38757045) (← links)
• Ubiquitin-dependent and independent roles of SUMO in proteostasis (Q38874015) (← links)
• Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity (Q38940963) (← links)
• The Roles of SUMO in Metabolic Regulation (Q39136006) (← links)
• SUMOylation of the Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 2 Increases Surface Expression and the Maximal Conductance of the Hyperpolarization-Activated Current (Q41299145) (← links)
• Interplay between sumoylation and phosphorylation for protection against α-synuclein inclusions (Q42983118) (← links)
• Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration (Q47564897) (← links)
• Sumoylation: Implications for Neurodegenerative Diseases (Q47799714) (← links)
• SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function. (Q52367004) (← links)
• SUMOylation in neuroplasticity and neurological disorders. (Q54418508) (← links)
• Sumoylation Protects Against β-Synuclein Toxicity in Yeast. (Q55058782) (← links)
• The SUMO-Conjugase Ubc9 Prevents the Degradation of the Dopamine Transporter, Enhancing Its Cell Surface Level and Dopamine Uptake (Q64271803) (← links)
• SUMOylation in development and neurodegeneration (Q90436538) (← links)
• SUMOylation and calcium signalling: potential roles in the brain and beyond (Q97884803) (← links)